Position in OGN
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$433
+$242 QoQ
Shares Held
32
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#525
of 626 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Physician Wealth Advisors, Inc. holds $3,911,594 across 15 Drug Manufacturers - General names. OGN ranks #15 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,025 | $1,229,415 | |
| 2 | JNJ |
Johnson & Johnson
|
3,392 | $861,466 | |
| 3 | MRK |
Merck & Co., Inc.
|
4,682 | $601,637 | |
| 4 | ABBV |
AbbVie Inc.
|
1,376 | $346,256 | |
| 5 | NVS |
Novartis AG
|
1,603 | $251,222 | |
| 6 | PFE |
Pfizer Inc
|
10,105 | $243,328 | |
| 7 | AZN |
Astrazeneca PLC
|
492 | $93,293 | |
| 8 | AMGN |
Amgen Inc
|
235 | $85,098 |
All Filings in OGN
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $433 | 32 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $191 | 32 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $229 | 32 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $341 | 32 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $309 | 32 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $476 | 32 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $477 | 32 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||